| Mindi E Cohen, DO | |
|
15825 Shady Grove Rd, Suite 140, Rockville, MD 20850-4008 | |
| (301) 869-9776 | |
| (301) 216-2592 |
| Full Name | Mindi E Cohen |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 34 Years |
| Location | 15825 Shady Grove Rd, Rockville, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104811553 | NPI | - | NPPES |
| 405789900 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | H0046438 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Home Health Services | Silver spring, MD | Home health agency |
| Sibley Memorial Hospital | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Comprehensive Primary Care And Associates Llc | 5092991984 | 49 |
News Archive
QLT Inc. today announced interim results from the first 3 subjects enrolled in a Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber congenital amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and significant visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of visual function.
A team of scientists from the University of California Santa Cruz, USA, recently identified a novel variant (B.1.x) of SARS-CoV-2 that might be circulating in at least 20 US states and six countries globally.
In a bid to rally support for the health overhaul among doctors, a White House official underscored both sticks and carrots the federal government is offering the health industry, Reuters reports: "Administration officials said the new law will provide doctors with information technology and incentives to improve the care they deliver, but only if they cooperate.
Oxygen Biotherapeutics, Inc. today announced that the company has submitted a patent application for a new invention that uses Oxycyte(R) perfluorocarbon to deliver oxygen as a first aid treatment for victims of heart attacks and strokes. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
Findings released today and detailed in the analysis Low Consumption and Higher Medicare Cost: Consumption Clusters in a Medicare Fee-for-Service Population, examine how individuals utilize benefits and services under the Medicare program.
› Verified 1 days ago
| Entity Name | Comprehensive Primary Care And Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831492586 PECOS PAC ID: 5092991984 Enrollment ID: O20110510000453 |
News Archive
QLT Inc. today announced interim results from the first 3 subjects enrolled in a Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber congenital amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and significant visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of visual function.
A team of scientists from the University of California Santa Cruz, USA, recently identified a novel variant (B.1.x) of SARS-CoV-2 that might be circulating in at least 20 US states and six countries globally.
In a bid to rally support for the health overhaul among doctors, a White House official underscored both sticks and carrots the federal government is offering the health industry, Reuters reports: "Administration officials said the new law will provide doctors with information technology and incentives to improve the care they deliver, but only if they cooperate.
Oxygen Biotherapeutics, Inc. today announced that the company has submitted a patent application for a new invention that uses Oxycyte(R) perfluorocarbon to deliver oxygen as a first aid treatment for victims of heart attacks and strokes. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
Findings released today and detailed in the analysis Low Consumption and Higher Medicare Cost: Consumption Clusters in a Medicare Fee-for-Service Population, examine how individuals utilize benefits and services under the Medicare program.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mindi E Cohen, DO 15825 Shady Grove Rd, Suite 140, Rockville, MD 20850-4008 Ph: (301) 869-9776 | Mindi E Cohen, DO 15825 Shady Grove Rd, Suite 140, Rockville, MD 20850-4008 Ph: (301) 869-9776 |
News Archive
QLT Inc. today announced interim results from the first 3 subjects enrolled in a Phase 1b clinical proof-of-concept study of QLT091001 in the treatment of Leber congenital amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and significant visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of visual function.
A team of scientists from the University of California Santa Cruz, USA, recently identified a novel variant (B.1.x) of SARS-CoV-2 that might be circulating in at least 20 US states and six countries globally.
In a bid to rally support for the health overhaul among doctors, a White House official underscored both sticks and carrots the federal government is offering the health industry, Reuters reports: "Administration officials said the new law will provide doctors with information technology and incentives to improve the care they deliver, but only if they cooperate.
Oxygen Biotherapeutics, Inc. today announced that the company has submitted a patent application for a new invention that uses Oxycyte(R) perfluorocarbon to deliver oxygen as a first aid treatment for victims of heart attacks and strokes. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
Findings released today and detailed in the analysis Low Consumption and Higher Medicare Cost: Consumption Clusters in a Medicare Fee-for-Service Population, examine how individuals utilize benefits and services under the Medicare program.
› Verified 1 days ago
Fudia Kallay, Family Medicine Medicare: Medicare Enrolled Practice Location: 9909 Medical Center Dr, Rockville, MD 20850 Phone: 240-684-6150 | |
Dr. Jack Richard Epstein, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 121 Congressional Ln, Suite 318, Rockville, MD 20852 Phone: 301-984-8689 Fax: 301-984-4843 | |
Dr. Hua-chuan Sim, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10960 Bloomingdale Dr, Rockville, MD 20852 Phone: 301-801-5400 | |
Dr. Joseph Gebeily, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15215 Shady Grove Road, Suite 203, Rockville, MD 20850 Phone: 301-500-0374 Fax: 301-560-5665 | |
Jin Moon Kang, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 15225 Shady Grove Rd, Suite 102, Rockville, MD 20850 Phone: 301-330-0661 Fax: 301-977-6940 | |
Sayed Elsayyad, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10110 Molecular Dr Ste 114, Rockville, MD 20850 Phone: 301-780-4745 Fax: 301-605-7550 | |
Dr. Praveen Kumar Gupta, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 50 West Edmonston Drive, #202, Rockville, MD 20852 Phone: 301-762-0788 Fax: 301-762-3130 |